These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6995017)

  • 1. Effect of 1 alpha-hydroxycholecalciferol on the skeletal mineral metabolism and bone morphogenesis.
    Iwata H; Mutoh Y; Mizutani H; Nakagawa M
    Contrib Nephrol; 1980; 22():74-88. PubMed ID: 6995017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; de Luca HF
    Proc Eur Dial Transplant Assoc; 1976; 12():227-36. PubMed ID: 935115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1 alpha-hydroxycholecalciferol on bone mass and composition of cortical bone in adult male rats.
    Lindholm TS; Nilsson OS; Eriksson S
    Isr J Med Sci; 1981 Jun; 17(6):416-21. PubMed ID: 6167532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse.
    Garba MT; Marie PJ
    Calcif Tissue Int; 1986 May; 38(5):296-302. PubMed ID: 3087604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 1 alpha(OH)-vitamin D3 and 24,25(OH)2-vitamin D3 on long bones of glucocorticoid-treated rats.
    Turnquist J; Ornoy A; Eini D; Schwartz Z
    Acta Anat (Basel); 1992; 145(1):61-7. PubMed ID: 1414214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1 alpha-OH-D3 on bone mineral content in the forearm of chronic hemodialyzed patients.
    Manji T; Kobayashi K
    Contrib Nephrol; 1980; 22():39-50. PubMed ID: 7398338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of calcium intake, 1-alpha(OH)D3, and etidronate on bone.
    Menczel J; Singer L; Ophaug RH
    Bone; 1987; 8(2):91-4. PubMed ID: 3036192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of osteoinduction by vitamin D metabolites in rachitic host rats.
    Atkin I; Dean DD; Muniz OE; Agundez A; Castiglione G; Cohen G; Howell DS; Ornoy A
    J Bone Miner Res; 1992 Aug; 7(8):863-75. PubMed ID: 1442201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of 1 alpha-OH-D3 on the bone metabolism after high tibial osteotomy].
    Yamashita I; Miyatsu M; Kamo Y; Atsuta Y; Onozawa T
    Nihon Seikeigeka Gakkai Zasshi; 1993 Sep; 67(9):804-15. PubMed ID: 8409641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
    Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
    [No Abstract]   [Full Text] [Related]  

  • 11. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
    Nielsen HE; Rømer FK; Melsen F; Christensen MS; Hansen HE
    Clin Nephrol; 1980 Mar; 13(3):103-8. PubMed ID: 7379358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bone inductive capacity of decalcified bone matrix modified by diphenylhydantoin.
    Oikarinen J
    Acta Orthop Scand; 1981 Oct; 52(5):505-11. PubMed ID: 6277145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antirachitic activity of 1 alpha-hydroxyergocalciferol and 1 alpha-hydroxycholecalciferol in rats.
    Sjöden G; Lindgren JU; DeLuca HF
    J Nutr; 1984 Nov; 114(11):2043-6. PubMed ID: 6333501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of 1 alpha-OH-D3 on the process of fracture healing (author's transl)].
    Tanaka J
    Nihon Seikeigeka Gakkai Zasshi; 1980 Aug; 54(8):749-65. PubMed ID: 7205041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone changes in rats with adjuvant arthritis: treatment with 1 alpha-hydroxycholecalciferol.
    Binderup L
    Acta Pharmacol Toxicol (Copenh); 1986 Sep; 59(3):228-35. PubMed ID: 3799201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial calcifications in uraemic rats treated with 1-alpha-hydroxycholecalciferol and parathyroidectomy.
    Krog M; Ejerblad S; Eriksson I; Johansson H
    Scand J Urol Nephrol; 1984; 18(3):227-39. PubMed ID: 6494830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aortic content of glycosaminoglycans, hydroxyproline and calcium in experimental uraemia with special reference to parathyroidectomy and vitamin-D treatment.
    Krog M; Ejerblad S; Johansson H
    Scand J Urol Nephrol; 1984; 18(3):241-7. PubMed ID: 6494831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
    Weber K; Goldberg M; Stangassinger M; Erben RG
    J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 1 alpha-hydroxycholecalciferol administration on Mg metabolism in sheep.
    Matsui T; Harumoto T; Yano H; Kawashima R
    J Nutr Sci Vitaminol (Tokyo); 1990 Apr; 36(2):99-104. PubMed ID: 2388100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 1 alpha-hydroxyvitamin D3 on cancellous bone matrix. An experimental study on adult rats.
    Lindholm TS; Nilsson OS; Lindholm TC
    Acta Orthop Scand; 1981 Oct; 52(5):497-503. PubMed ID: 6174018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.